|
| HOME |
|
Archive News
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.
If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.
| 2003 |
|
|
| December 18, 2003 |
Formal Resolution to Abbott Dispute |
|
| December 11, 2003 |
Domantis - Dual Targeting dAbs |
|
| December 6, 2003 |
Joint Venture with Biosceptre |
|
| December 3, 2003 |
Resolution to Abbott Dispute |
|
| December 3, 2003 |
New Director |
|
| November 21, 2003 |
New Ovuplant® European distributor |
|
| November 5, 2003 |
Abbott ASX2 |
|
| October 30, 2003 |
Centocor Arbitration |
|
| September 17, 2003 |
Suprelorin® Australian approval |
|
| September 12, 2003 |
Humira European Approval |
|
| September 11, 2003 |
August 03 Presentation |
|
| August 21, 2003 |
MD Retirement |
|
| August 21, 2003 |
Domantis Presentation |
|
| August 1, 2003 |
Domantis and EvoGenix to collaborate |
|
| July 10, 2003 |
Media Release Half Year Report |
|
| July 5, 2003 |
Domantis pre-clinical |
|
| July 3, 2003 |
Suprelorin® NZ Approval |
|
| July 1, 2003 |
Humira Announcement |
|
| June 24, 2003 |
Domantis-ImClone |
|
| June 14, 2003 |
Anti-TNF FDA |
|
| June 14, 2003 |
Centocor update |
|
| May 30, 2003 |
Scios-469 |
|
| May 27, 2003 |
EvoGenix Pty Limited announced today that it had been awarded an Australian Federal
Government START grant of $900,000 to support its therapeutics development
program over the next two years |
|
| May 15, 2003 |
Chairman's Presentation |
|
| May 14, 2003 |
Centocor Update |
|
| May 3, 2003 |
Peptech AGM 2003 Follow-Up |
|
| April 23, 2003 |
Peptech AGM 2003 Presentation |
|
| April 16, 2003 |
Chairman's AGM Address |
|
| April 13, 2003 |
EvoGenix announces collaboration with New Zealand’s Genesis Research and Development Corporation, to jointly develop anti-inflammatory drugs against a novel immunomodulator target |
|
| April 11, 2003 |
MD's AGM Address |
|
| April 10, 2003 |
Peptech anti-TNF domain antibodies to enter pre-clinical studies and Peptech Domantis early payment |
|
| April 3, 2003 |
Domantis Press Release on Grant of Patent |
|
| March 4, 2003 |
Domantis Holmes appointment |
|
| March 1, 2003 |
ASX Query |
|
| February 27, 2003 |
Peptech Announces Share Placement |
|
| February 22, 2003 |
Abbott Humira USA approval |
|
| February 22, 2003 |
Peptech US Anti TNF Patent 6498237 issued |
|
| February 20, 2003 |
EvoGenix has announced the appointment of antibody engineering pioneer Dr Hennie Hoogenboom as an adviser to the company |
|
| January 16, 2003 |
EvoGenix announces grant of key patent in the USA – “Patent grant gives marketing edge” |
|
| |
|
|
|
